Sun F, Nagpal S, Singhal S, Neal JW, et al. Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer. Clin Lung Cancer 2025 Aug 6:S1525-7304(25)00165.
PMID: 40885626